Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
Nancy A Dreyer(IQVIA (United Kingdom)), Stephen Toovey, Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Lisa Albert(IQVIA (United States)), Damir Mohamed(IQVIA (France)), Matthew W. Reynolds(IQVIA (United States)), Emma Brinkley(IQVIA (United States))
Cited by 26
Related Papers
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms
|Pharmacoepidemiology and Drug Safety|2020|120
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
|Annals of the Rheumatic Diseases|2023|95
Methods for external control groups for single arm trials or <scp>long‐term</scp> uncontrolled extensions to randomized clinical trials
|Pharmacoepidemiology and Drug Safety|2020|68
Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study
|American Journal of Epidemiology|2020|66